Yahoo! Finance: Biotechnology Industry News: Pharming and Santarus announce poster presentation of pivotal clinical data for RUCONEST® (recombinant human C1 esterase inhibitor)

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

Pharming and Santarus announce poster presentation of pivotal clinical data for RUCONEST® (recombinant human C1 esterase inhibitor) Jun 25th 2013, 05:03 [Thomson Reuters ONE] - LEIDEN, Netherlands and SAN DIEGO (June 25, 2013) - Pharming Group NV (NYSE Euronext: PHARM) and Santarus, Inc. (NASDAQ: SNTS), announced that new data from a pivotal Phase III clinical study with RUCONEST ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions